146 related articles for article (PubMed ID: 34154795)
41. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
[TBL] [Abstract][Full Text] [Related]
42. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
[TBL] [Abstract][Full Text] [Related]
43. Intralesional cidofovir and surgical excision for laryngeal papillomatosis.
Naiman AN; Ceruse P; Coulombeau B; Froehlich P
Laryngoscope; 2003 Dec; 113(12):2174-81. PubMed ID: 14660923
[TBL] [Abstract][Full Text] [Related]
44. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
Bielecki I; Mniszek J; Cofała M
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450
[TBL] [Abstract][Full Text] [Related]
45. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
Chung BJ; Akst LM; Koltai PJ
Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
[TBL] [Abstract][Full Text] [Related]
46. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Chirilă M; Bolboacă SD
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1135-42. PubMed ID: 24121781
[TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir.
Pransky SM; Albright JT; Magit AE
Laryngoscope; 2003 Sep; 113(9):1583-7. PubMed ID: 12972938
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
49. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Durvasula VS; Richter GT
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
[TBL] [Abstract][Full Text] [Related]
50. Is recurrent respiratory papillomatosis a manageable or curable disease?
Kim HT; Baizhumanova AS
Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
[TBL] [Abstract][Full Text] [Related]
51. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
[TBL] [Abstract][Full Text] [Related]
52. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
Pudszuhn A; Welzel C; Bloching M; Neumann K
Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
[TBL] [Abstract][Full Text] [Related]
53. Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.
Ballestas SA; Hidalgo Lopez J; Klein AM; Steuer C; Shin DM; Abousaud M; Schmitt NC; Teng Y; Saba NF; Tkaczuk AT
Laryngoscope; 2023 Oct; 133(10):2725-2733. PubMed ID: 36815602
[TBL] [Abstract][Full Text] [Related]
54. Recurrent respiratory papillomatosis: the role of cidofovir.
Tran MN; Galt L; Bashirzadeh F
Respirol Case Rep; 2018 Nov; 6(8):e00371. PubMed ID: 30302253
[TBL] [Abstract][Full Text] [Related]
55. Intralesional Bevacizumab as Adjuvant Therapy for Juvenile Onset Recurrent Respiratory Papillomatosis: A Systematic Review.
Guragain R; Gyawali BR
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):1296-1301. PubMed ID: 37275063
[No Abstract] [Full Text] [Related]
56. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir.
Chhetri DK; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1081-5. PubMed ID: 14568791
[TBL] [Abstract][Full Text] [Related]
57. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
[TBL] [Abstract][Full Text] [Related]
58. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis.
Mohr M; Schliemann C; Biermann C; Schmidt LH; Kessler T; Schmidt J; Wiebe K; Müller KM; Hoffmann TK; Groll AH; Werner C; Kessler C; Wiewrodt R; Rudack C; Berdel WE
Oncol Lett; 2014 Nov; 8(5):1912-1918. PubMed ID: 25289079
[TBL] [Abstract][Full Text] [Related]
59. Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: A series of three pediatric cases and literature review.
Enrique OH; Eloy SH; Adrian TP; Perla V
Am J Otolaryngol; 2021; 42(5):103126. PubMed ID: 34175693
[TBL] [Abstract][Full Text] [Related]
60. Intralesional cidofovir for recurrent respiratory papillomatosis in children.
Pransky SM; Magit AE; Kearns DB; Kang DR; Duncan NO
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1143-8. PubMed ID: 10522508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
